{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T19:26:54Z","timestamp":1785612414498,"version":"3.56.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is the most common form of age-related neurodegenerative disease. Unfortunately, due to the complexity of pathological types and clinical heterogeneity of AD, there is a lack of satisfactory treatment for AD. Previous studies have shown that microRNAs and transcription factors can modulate genes associated with AD, but the underlying pathophysiology remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The datasets GSE1297 and GSE5281 were downloaded from the gene expression omnibus (GEO) database and analyzed to obtain the differentially expressed genes (DEGs) through the \u201cR\u201d language \u201climma\u201d package. The GSE1297 dataset was analyzed by weighted correlation network analysis (WGCNA), and the key gene modules were selected. Next, gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis for the key gene modules were performed. Then, the protein-protein interaction (PPI) network was constructed and the hub genes were identified using the STRING database and Cytoscape software. Finally, for the GSE150693 dataset, the \u201cR\u201d package \u201csurvivation\u201d was used to integrate the data of survival time, AD transformation status and 35 characteristics, and the key microRNAs (miRNAs) were selected by Cox method. We also performed regression analysis using least absolute shrinkage and selection operator (Lasso)-Cox to construct and validate prognostic features associated with the four key genes using different databases. We also tried to find drugs targeting key genes through DrugBank database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>GO and KEGG enrichment analysis showed that DEGs were mainly enriched in pathways regulating chemical synaptic transmission, glutamatergic synapses and Huntington\u2019s disease. In addition, 10 hub genes were selected from the PPI network by using the algorithm Between Centrality. Then, four core genes (TBP, CDK7, GRM5, and GRIA1) were selected by correlation with clinical information, and the established model had very good prognosis in different databases. Finally, hsa-miR-425-5p and hsa-miR-186-5p were determined by COX regression, AD transformation status and aberrant miRNAs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In conclusion, we tried to construct a network in which miRNAs and transcription factors jointly regulate pathogenic genes, and described the process that abnormal miRNAs and abnormal transcription factors TBP and CDK7 jointly regulate the transcription of AD central genes GRM5 and GRIA1. The insights gained from this study offer the potential AD biomarkers, which may be of assistance to the diagnose and therapy of AD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2022.1069606","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:47:37Z","timestamp":1670334457000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Preliminary exploration of the co-regulation of Alzheimer\u2019s disease pathogenic genes by microRNAs and transcription factors"],"prefix":"10.3389","volume":"14","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-3940(99)00617-5","article-title":"Cerebrospinal fluid tau and A\u03b242 as predictors of development of Alzheimer\u2019s disease in patients with mild cognitive impairment.","volume":"273","author":"Andreasen","year":"1999","journal-title":"Neurosci. Lett."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0199-2","article-title":"Absent sleep EEG spindle activity in GluA1 (Gria1) knockout mice: Relevance to neuropsychiatric disorders.","volume":"8","author":"Ang","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1001\/jama.2019.11653","article-title":"What is dementia?.","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia.","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"Jama"},{"key":"B5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40265-015-0529-0","article-title":"Tau Biology and Tau-Directed Therapies for Alzheimer\u2019s Disease.","volume":"76","author":"Bakota","year":"2016","journal-title":"Drugs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/mp.2014.91","article-title":"What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit.","volume":"19","author":"Barkus","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1515\/hsz-2019-0407","article-title":"Hsa-miR-186-5p regulates TGF\u03b2 signaling pathway through expression suppression of SMAD6 and SMAD7 genes in colorectal cancer.","volume":"402","author":"Bayat","year":"2021","journal-title":"Biol. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.parkreldis.2009.06.006","article-title":"Huntington\u2019s disease-like and ataxia syndromes: Identification of a family with a de novo SCA17\/TBP mutation.","volume":"16","author":"Bech","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.0308512100","article-title":"Incipient Alzheimer\u2019s disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses.","volume":"101","author":"Blalock","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142756","article-title":"Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer\u2019s Disease.","volume":"10","author":"Byun","year":"2015","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.7150\/thno.47408","article-title":"Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer\u2019s disease by enhancing autophagy.","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10571-017-0574-1","article-title":"Tau Proteins and Tauopathies in Alzheimer\u2019s Disease.","volume":"38","author":"Chong","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/archneur.56.7.857","article-title":"Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: A clinical perspective of data from the Consortium to Establish a Registry for Alzheimer\u2019s Disease.","volume":"56","author":"Clark","year":"1999","journal-title":"Arch. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/b978-0-12-385506-0.00002-8","article-title":"Therapeutic targets in Alzheimer\u2019s disease and related tauopathies.","volume":"98","author":"Corbo","year":"2011","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1002\/gps.938","article-title":"The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer\u2019s disease: Preclinical evidence.","volume":"18","author":"Danysz","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1051\/medsci\/2004205575","article-title":"TBP, a universal transcription factor?.","volume":"20","author":"Davidson","year":"2004","journal-title":"Med. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","article-title":"Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.","volume":"100","author":"Dejanovic","year":"2018","journal-title":"Neuron"},{"key":"B18","first-page":"41","article-title":"Alzheimer\u2019s disease and the glutamate NMDA receptor.","volume":"37","author":"Doraiswamy","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/00207454.2020.1715977","article-title":"Activating transcription factor 6 reduces A\u03b21-42 and restores memory in Alzheimer\u2019s disease model mice.","volume":"130","author":"Du","year":"2020","journal-title":"Int. J. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease.","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/21541264.2016.1268244","article-title":"CDK regulation of transcription by RNAP II: Not over \u2018til it\u2019s over?","volume":"8","author":"Fisher","year":"2017","journal-title":"Transcription"},{"key":"B22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/21541264.2018.1553483","article-title":"Cdk7: A kinase at the core of transcription and in the crosshairs of cancer drug discovery.","volume":"10","author":"Fisher","year":"2019","journal-title":"Transcription"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s11011-019-00438-9","article-title":"Intrahippocampal miR-342-3p inhibition reduces \u03b2-amyloid plaques and ameliorates learning and memory in Alzheimer\u2019s disease.","volume":"34","author":"Fu","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.4268\/cjcmm20161522","article-title":"Effect of hyperforin on learning and memory abilities and A\u03b21\u201342, \u03b2APP and BACE1 protein expressions in hippocampus of Alzheimer\u2019s disease model mice.","volume":"41","author":"Geng","year":"2016","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0414-z","article-title":"Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer\u2019s disease.","volume":"5","author":"Hara","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00365","article-title":"Cdk7 Is Required for Activity-Dependent Neuronal Gene Expression, Long-Lasting Synaptic Plasticity and Long-Term Memory.","volume":"10","author":"He","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/s0197-4580(97)00066-3","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease: Clinical-pathological studies.","volume":"18","author":"Hyman","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer\u2019s disease.","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem. Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ALZ.12366","article-title":"Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis.","volume":"18","author":"J\u00e4kel","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nmeth.3178","article-title":"In silico prediction of physical protein interactions and characterization of interactome orphans.","volume":"12","author":"Kotlyar","year":"2015","journal-title":"Nat. Methods"},{"key":"B31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1042\/bst20180623","article-title":"Transcription initiation factor TBP: Old friend new questions.","volume":"47","author":"Kramm","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"B32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay.","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.3233\/jad-190583","article-title":"A New Discovery of MicroRNA-455-3p in Alzheimer\u2019s Disease.","volume":"72","author":"Kumar","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1093\/hmg\/ddx267","article-title":"MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer\u2019s disease.","volume":"26","author":"Kumar","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/ene.15043","article-title":"Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer\u2019s disease.","volume":"29","author":"Kurucu","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt155","article-title":"Clinical, imaging, and pathological heterogeneity of the Alzheimer\u2019s disease syndrome.","volume":"5","author":"Lam","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-7-r78","article-title":"A blood based 12-miRNA signature of Alzheimer disease patients.","volume":"14","author":"Leidinger","year":"2013","journal-title":"Genome Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1152\/physiolgenomics.00208.2006","article-title":"Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain.","volume":"28","author":"Liang","year":"2007","journal-title":"Physiol. Genom."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120747","article-title":"Retraction notice to \u201cOsthole attenuates APP-induced Alzheimer\u2019s disease through up-regulating miRNA-101a-3p\u201d [Life Sci. 225 (2019) 117-131].","volume":"305","author":"Lin","year":"2022","journal-title":"Life Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1080\/15384101.2020.1783058","article-title":"Hsa-miR-425-5p promotes tumor growth and metastasis by activating the CTNND1-mediated \u03b2-catenin pathway and EMT in colorectal cancer.","volume":"19","author":"Liu","year":"2020","journal-title":"Cell Cycle"},{"key":"B41","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: An update on pathobiology and treatment strategies.","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuropharm.2015.08.003","article-title":"Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment.","volume":"115","author":"Matosin","year":"2017","journal-title":"Neuropharmacology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11682-017-9712-0","article-title":"Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia.","volume":"12","author":"Matosin","year":"2018","journal-title":"Brain Imaging Behav."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006239","article-title":"Epidemiology of Alzheimer Disease.","volume":"8","author":"Mayeux","year":"2012","journal-title":"Cold Spring Harb. Prespect. Med."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.146581","article-title":"Role of the TATA-box binding protein (TBP) and associated family members in transcription regulation.","volume":"833","author":"Mishal","year":"2022","journal-title":"Gene"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/ALZ.12321","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: A clinicopathologic perspective for biomarker research.","volume":"17","author":"Moloney","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e08518","article-title":"Immune gene network of neurological diseases: Multiple sclerosis (MS), Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD) and Huntington\u2019s disease (HD).","volume":"7","author":"Mukherjee","year":"2021","journal-title":"Heliyon"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.bbrc.2016.07.122","article-title":"Mitochondrial Ca(2+) handling in Huntington\u2019s and Alzheimer\u2019s diseases - Role of ER-mitochondria crosstalk.","volume":"483","author":"Naia","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000307675.38908.39","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons.","volume":"70","author":"Nandigam","year":"2008","journal-title":"Neurology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbr.2016.06.002","article-title":"Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer\u2019s disease mouse models.","volume":"322","author":"Neuner","year":"2017","journal-title":"Behav. Brain Res."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101206","article-title":"Nrf2: A dark horse in Alzheimer\u2019s disease treatment.","volume":"64","author":"Osama","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41589-020-0563-4","article-title":"Dissecting the Pol II transcription cycle and derailing cancer with CDK inhibitors.","volume":"16","author":"Parua","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1096\/fj.201801846R","article-title":"Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer\u2019s disease.","volume":"33","author":"Qian","year":"2019","journal-title":"Faseb J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.molbrainres.2004.03.018","article-title":"TBP, a polyglutamine tract containing protein, accumulates in Alzheimer\u2019s disease.","volume":"125","author":"Reid","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jdermsci.2008.10.004","article-title":"MicroRNAs and the skin: Tiny players in the body\u2019s largest organ.","volume":"53","author":"Sand","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4161\/trns.25146","article-title":"Pause, play, repeat: CDKs push RNAP II\u2019s buttons.","volume":"4","author":"Sans\u00f3","year":"2013","journal-title":"Transcription"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-008-1092-0","article-title":"Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: Participation of the phospholipase A2 enzyme.","volume":"198","author":"Schaeffer","year":"2008","journal-title":"Psychopharmacology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1212\/wnl.55.3.370","article-title":"Preclinical\u201d AD revisited: Neuropathology of cognitively normal older adults.","volume":"55","author":"Schmitt","year":"2000","journal-title":"Neurology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00401-011-0843-x","article-title":"Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced A\u03b2 and tau pathology in transgenic mouse models of Alzheimer\u2019s disease.","volume":"122","author":"Shao","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.36","article-title":"Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform.","volume":"1","author":"Shen","year":"2022","journal-title":"Imeta"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00716-0","article-title":"Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer\u2019s disease created by integrative analysis of multi-omics data.","volume":"12","author":"Shigemizu","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/1871527316666170113120853","article-title":"Synaptic Plasticity, Dementia and Alzheimer Disease.","volume":"16","author":"Skaper","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13069","article-title":"A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer\u2019s disease models.","volume":"19","author":"Song","year":"2020","journal-title":"Aging Cell."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ijbiomac.2018.09.056","article-title":"Differentially expressed gene (DEG) based protein-protein interaction (PPI) network identifies a spectrum of gene interactome, transcriptome and correlated miRNA in nondisjunction Down syndrome.","volume":"122","author":"Sriroopreddy","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","article-title":"MAPT mutations, tauopathy, and mechanisms of neurodegeneration.","volume":"99","author":"Strang","year":"2019","journal-title":"Lab. Invest."},{"key":"B66","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","article-title":"Systematic Review of miRNA as Biomarkers in Alzheimer\u2019s Disease.","volume":"56","author":"Swarbrick","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050546","article-title":"Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer\u2019s Disease, in Silico Trials.","volume":"15","author":"\u015awietlik","year":"2022","journal-title":"Pharmaceuticals"},{"key":"B68","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: Protein-protein interaction networks, integrated over the tree of life.","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B69","first-page":"607","article-title":"Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer\u2019s disease and vascular dementia.","volume":"42","author":"Tanovi\u0107","year":"2006","journal-title":"Rev. Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/ageing\/afl108","article-title":"Sporadic cerebral amyloid angiopathy\u2014an important cause of cerebral haemorrhage in older people.","volume":"35","author":"Thanvi","year":"2006","journal-title":"Age Ageing"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188491","article-title":"Non-coding RNAs and potential therapeutic targeting in cancer.","volume":"1875","author":"Toden","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1042\/bst20150157","article-title":"Mechanisms of regulation of mature miRNAs.","volume":"43","author":"Towler","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"B73","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.neuroscience.2005.03.024","article-title":"TATA-binding protein in neurodegenerative disease.","volume":"133","author":"van Roon-Mom","year":"2005","journal-title":"Neuroscience"},{"key":"B74","doi-asserted-by":"publisher","first-page":"618","DOI":"10.2174\/138920210793360943","article-title":"Functional Genomics of Brain Aging and Alzheimer\u2019s Disease: Focus on Selective Neuronal Vulnerability.","volume":"11","author":"Wang","year":"2010","journal-title":"Curr. Genom."},{"key":"B75","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A major update to the DrugBank database for 2018.","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/cam4.3643","article-title":"Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma: A study based on bioinformatics analysis.","volume":"10","author":"Wu","year":"2021","journal-title":"Cancer Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"12137","DOI":"10.1523\/jneurosci.0705-15.2015","article-title":"Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing A\u03b2 Generation and Amyloid Plaque Pathogenesis.","volume":"35","author":"Xiao","year":"2015","journal-title":"J. Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"15569","DOI":"10.18632\/aging.203118","article-title":"Repressor element-1 silencing transcription factor regulates glutamate receptors and immediate early genes to affect synaptic plasticity.","volume":"13","author":"Xu","year":"2021","journal-title":"Aging"},{"key":"B79","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1093\/cercor\/bhab515","article-title":"miRNA-126a-3p Participates in Hippocampal Memory via Alzheimer\u2019s Disease-Related Proteins.","volume":"32","author":"Xue","year":"2022","journal-title":"Cereb. Cortex"},{"key":"B80","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1046\/j.1440-1789.2003.00522.x","article-title":"Senile dementia of the neurofibrillary tangle type (tangle-only dementia): Neuropathological criteria and clinical guidelines for diagnosis.","volume":"23","author":"Yamada","year":"2003","journal-title":"Neuropathology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.apsb.2022.01.017","article-title":"Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer\u2019s disease therapy.","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B82","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1080\/15548627.2021.1886720","article-title":"Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB).","volume":"17","author":"Zheng","year":"2021","journal-title":"Autophagy"},{"key":"B84","doi-asserted-by":"publisher","first-page":"43506","DOI":"10.18632\/oncotarget.16490","article-title":"The associations between the MAPT polymorphisms and Alzheimer\u2019s disease risk: A meta-analysis.","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"B85","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/s0197-4580(00)00217-7","article-title":"Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease.","volume":"21","author":"Zhu","year":"2000","journal-title":"Neurobiol. Aging"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.1069606\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:47:40Z","timestamp":1670334460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.1069606\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":85,"alternative-id":["10.3389\/fnagi.2022.1069606"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.1069606","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"article-number":"1069606"}}